SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16642George, a few questions. Will Citigroup now demand a seat or seats on the boardBluegreen-2/18/2004
16641Well one thing you do understand about biotech is the lack of transparency. I caRobert K.-2/16/2004
16640Of note >Genimune™: During 2001, in order to focus development activities on Robert K.-2/16/2004
16639The writing is on the wall so to speak..................... ........>(read veRobert K.-2/16/2004
16638Robert, I am not in any biotech at the moment. The fault is mine. I just am noaknahow-2/16/2004
16637Certainly many more stocks than xoma. Biotech I also have sepr, crgn, cphd, hgsiRobert K.-2/16/2004
16636When i was in I saw many things as peachy but complained constantly about many oaknahow-2/16/2004
16635George. Just some friendly advice. >I fully understand your motivation to notRobert K.-2/16/2004
16634One more point on jacks wording.>">""This pilot study is thRobert K.-2/16/2004
16633Blue> it would be useful to find out for sure if 1. if cpb is open label 2. iRobert K.-2/16/2004
16632Quote of the day >""This pilot study is the first in a series of poRobert K.-2/16/2004
16631George, I WELCOME any NEGATIVE thoughts or concerns about Xoma. It seems as thoBluegreen-2/16/2004
16630Joke of the day > regarding CIBC's recent downgrade>>>>. AccRobert K.-2/16/2004
16629From the xoma website. Lets cut this statement down to size. "XOMA is evalRobert K.-2/16/2004
16628How about getting some "complimentary data" at any point from cpb and Robert K.-2/16/2004
16627And IMO a "submmit" is NOT impossible at all. And also I think the cpbRobert K.-2/16/2004
16626I would like to remind both of you that bpi-21 was never denied. >>>>Robert K.-2/16/2004
16625I agree 100% I fault management for not dealing with the FDA more forcefully. aknahow-2/16/2004
16624Let's not forget this also.>>>>>>>>http://www.fda.goBluegreen-2/16/2004
16623Bob, I emailed several executives at Xoma the just posted news article on sepsisBluegreen-2/16/2004
16622George, Neuprex had SUBPART E designation which only requires clinical benefit. Bluegreen-2/16/2004
16621I was a strong supporter of xoma based on bpi. I lost faith in xoma about 2002 bRobert K.-2/16/2004
16620The data is the data so one should be aware of what the FDA said in correspondenaknahow-2/16/2004
16619Bob, where was the FAST use of Neuprex????? Every time I read an article like tBluegreen-2/16/2004
16618Bob, another PSORIASIS CENTER. Here is an EXPERT that thinks the latest BiologiBluegreen-2/15/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News